Literature DB >> 3162021

Decreased level of suppressor/cytotoxic T cells (OKT8+) in polymyalgia rheumatica and temporal arteritis: relation to disease activity.

H Elling, P Elling.   

Abstract

Separated peripheral blood mononuclear cells were analyzed by fluorescent microscopy with monoclonal antisera for T cells (OKT3+), helper/inducer T cells (OKT4+) and suppressor/cytotoxic T cells (OKT8+). Thirty-seven patients with polymyalgia rheumatica (PMR), 13 of whom had positive biopsies for arteritis, were studied and compared with 25 age and sex matched normal subjects. The percentages of OKT3+ and OKT4+ T cells were similar in the PMR group and controls, but percentage of OKT8+ T cells was significantly reduced in patients (14.8 +/- 6.8) compared with controls (22.1 +/- 6.3). Values of OKT8+ T cells were extremely low in untreated patients with active, acute disease (7.8 +/- 4.4%) and significantly lower than in prednisone treated patients with inactive disease (17.3 +/- 5.9). These findings indicate that low values of circulating OKT8+ T cells is a feature of PMR and is related to disease activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3162021

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

Review 1.  Stopping steroids in polymyalgia rheumatica and giant cell arteritis.

Authors:  V Kyle; B L Hazelman
Journal:  BMJ       Date:  1990-02-10

2.  Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  B Dasgupta; O Duke; A M Timms; C Pitzalis; G S Panayi
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

3.  Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study.

Authors:  B Dasgupta; O Duke; V Kyle; D G Macfarlane; B L Hazleman; G S Panayi
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

4.  T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.

Authors:  R Andersson; R Jonsson; A Tarkowski; B A Bengtsson; B E Malmvall
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

5.  Peripheral blood lymphocyte subsets in polymyalgia rheumatica.

Authors:  A Uddhammar; G Roos; B Näsman; S R Dahlqvist
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

6.  Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.

Authors:  G D Pountain; M T Keogan; D L Brown; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

7.  T lymphocytes in giant cell arteritic lesions are polyclonal cells expressing alpha beta type antigen receptors and VLA-1 integrin receptors.

Authors:  C Schaufelberger; S Stemme; R Andersson; G K Hansson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

8.  The Cambridge dilemma.

Authors:  P Elling; H Elling; A T Olsson
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

9.  HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.

Authors:  R Andersson; G K Hansson; T Söderström; R Jonsson; B A Bengtsson; E Nordborg
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

10.  Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica.

Authors:  T Ellingsen; P Elling; A Olson; H Elling; U Baandrup; K Matsushima; B Deleuran; K Stengaard-Pedersen
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.